サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1457271

狂犬病ワクチンの世界市場規模、シェア、動向分析レポート：予防タイプ別、エンドユーザー別、用途別、製品タイプ別、地域別展望と予測、2023～2030年

Global Rabies Vaccine Market Size, Share & Trends Analysis Report By Prophylaxis Type, By End User, By Application, By Product Type, By Regional Outlook and Forecast, 2023 - 2030
出版日: | 発行: KBV Research | ページ情報: 英文 250 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
狂犬病ワクチンの世界市場規模、シェア、動向分析レポート：予防タイプ別、エンドユーザー別、用途別、製品タイプ別、地域別展望と予測、2023～2030年
出版日: 2024年03月14日
発行: KBV Research
ページ情報: 英文 250 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の狂犬病ワクチンの市場規模は、2030年までに16億米ドルに達すると予想されており、予測期間中に4.5%のCAGRで市場成長が見込まれます。

さらに、COVID-19パンデミックにより、ワクチン接種プログラムを含む日常的なヘルスケアサービスが混乱しました。ロックダウン、移動制限、ヘルスケアシステムの逼迫は、特に資源が限られた地域では、狂犬病ワクチン接種キャンペーンの実施に影響を与える可能性があります。渡航制限や世界の交通機関の混乱は、世界の保健への取り組みや協力に携わる専門家の移動に影響を与える可能性があります。これは、狂犬病を制御し撲滅するための世界の取り組みに影響を与えます。このように、COVID-19パンデミックは市場に適度な影響を与えました。

しかし、ワクチン接種プログラムの費用が高額であるため、特に資源に制約のある地域では、これらのワクチンへのアクセスが制限される可能性があります。公衆衛生への取り組みを担当する政府は、狂犬病ワクチン接種プログラムを実施する際に財政的負担を経験する可能性があります。これらのプログラムへのリソースの割り当ては、他の重要なヘルスケアニーズと競合する可能性があり、予算の制約につながる可能性があります。したがって、コストが高いと市場の成長が鈍化する可能性があります。

目次

第1章 市場範囲と調査手法

  • 市場の定義
  • 目的
  • 市場範囲
  • セグメンテーション
  • 調査手法

第2章 市場要覧

  • 主要なハイライト

第3章 市場概要

  • イントロダクション
    • 概要
      • 市場構成とシナリオ
  • 市場に影響を与える主要な要因
    • 市場促進要因
    • 市場機会
    • 市場抑制要因
    • 市場の課題
  • ポーターファイブフォース分析

第4章 世界市場：予防タイプ別

  • 世界の暴露後予防市場：地域別
  • 世界の曝露前予防市場：地域別

第5章 世界市場：エンドユーザー別

  • 世界の病院市場：地域別
  • 世界の動物病院市場：地域別
  • 世界のその他の市場：地域別

第6章 世界市場：用途別

  • 世界の人間市場：地域別
  • 世界の動物市場：地域別

第7章 世界市場：製品タイプ別

  • 世界の鶏胚細胞狂犬病ワクチン市場：地域別
  • 世界のヒト二倍体細胞ワクチン市場：地域別
  • 世界のベロセル狂犬病ワクチン市場：地域別
  • 世界のその他の市場：地域別

第8章 世界市場：地域別

  • 北米
    • 北米の市場：国別
      • 米国
      • カナダ
      • メキシコ
      • その他北米地域
  • 欧州
    • 欧州の市場：国別
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州地域
  • アジア太平洋
    • アジア太平洋の市場：国別
      • 中国
      • 日本
      • インド
      • 韓国
      • シンガポール
      • マレーシア
      • その他アジア太平洋
  • ラテンアメリカ・中東・アフリカ
    • ラテンアメリカ・中東・アフリカの市場：国別
      • ブラジル
      • アルゼンチン
      • アラブ首長国連邦
      • サウジアラビア
      • 南アフリカ
      • ナイジェリア
      • その他ラテンアメリカ・中東・アフリカ地域

第9章 企業プロファイル

  • Cadila Pharmaceuticals Limited
  • Bharat Biotech Ltd
  • Serum Institute of India Pvt Ltd.（Cyrus Poonawalla Group）
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health, Inc
  • Zoetis, Inc
  • Merck & Co, Inc.
  • Novartis AG
  • Sanofi SA
  • Virbac

第10章 狂犬病ワクチン市場の成功必須条件

図表

LIST OF TABLES

  • TABLE 1Global Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 2Global Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 3Global Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 4Global Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 5Global Post-exposure Prophylaxis Market by Region, 2019 - 2022, USD Million
  • TABLE 6Global Post-exposure Prophylaxis Market by Region, 2023 - 2030, USD Million
  • TABLE 7Global Pre-exposure prophylaxis Market by Region, 2019 - 2022, USD Million
  • TABLE 8Global Pre-exposure prophylaxis Market by Region, 2023 - 2030, USD Million
  • TABLE 9Global Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 10Global Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 11Global Hospitals Market by Region, 2019 - 2022, USD Million
  • TABLE 12Global Hospitals Market by Region, 2023 - 2030, USD Million
  • TABLE 13Global Veterinary Clinics Market by Region, 2019 - 2022, USD Million
  • TABLE 14Global Veterinary Clinics Market by Region, 2023 - 2030, USD Million
  • TABLE 15Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 16Global Others Market by Region, 2023 - 2030, USD Million
  • TABLE 17Global Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 18Global Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 19Global Human Market by Region, 2019 - 2022, USD Million
  • TABLE 20Global Human Market by Region, 2023 - 2030, USD Million
  • TABLE 21Global Animal Market by Region, 2019 - 2022, USD Million
  • TABLE 22Global Animal Market by Region, 2023 - 2030, USD Million
  • TABLE 23Global Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 24Global Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 25Global Chick Embryo Cells Rabies Vaccine Market by Region, 2019 - 2022, USD Million
  • TABLE 26Global Chick Embryo Cells Rabies Vaccine Market by Region, 2023 - 2030, USD Million
  • TABLE 27Global Human Diploid Cell Vaccine Market by Region, 2019 - 2022, USD Million
  • TABLE 28Global Human Diploid Cell Vaccine Market by Region, 2023 - 2030, USD Million
  • TABLE 29Global Vero Cell Rabies Vaccine Market by Region, 2019 - 2022, USD Million
  • TABLE 30Global Vero Cell Rabies Vaccine Market by Region, 2023 - 2030, USD Million
  • TABLE 31Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 32Global Others Market by Region, 2023 - 2030, USD Million
  • TABLE 33Global Rabies Vaccine Market by Region, 2019 - 2022, USD Million
  • TABLE 34Global Rabies Vaccine Market by Region, 2023 - 2030, USD Million
  • TABLE 35North America Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 36North America Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 37North America Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 38North America Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 39North America Post-exposure Prophylaxis Market by Region, 2019 - 2022, USD Million
  • TABLE 40North America Post-exposure Prophylaxis Market by Region, 2023 - 2030, USD Million
  • TABLE 41North America Pre-exposure prophylaxis Market by Region, 2019 - 2022, USD Million
  • TABLE 42North America Pre-exposure prophylaxis Market by Region, 2023 - 2030, USD Million
  • TABLE 43North America Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 44North America Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 45North America Hospitals Market by Country, 2019 - 2022, USD Million
  • TABLE 46North America Hospitals Market by Country, 2023 - 2030, USD Million
  • TABLE 47North America Veterinary Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 48North America Veterinary Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 49North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 50North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 51North America Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 52North America Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 53North America Human Market by Country, 2019 - 2022, USD Million
  • TABLE 54North America Human Market by Country, 2023 - 2030, USD Million
  • TABLE 55North America Animal Market by Country, 2019 - 2022, USD Million
  • TABLE 56North America Animal Market by Country, 2023 - 2030, USD Million
  • TABLE 57North America Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 58North America Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 59North America Chick Embryo Cells Rabies Vaccine Market by Country, 2019 - 2022, USD Million
  • TABLE 60North America Chick Embryo Cells Rabies Vaccine Market by Country, 2023 - 2030, USD Million
  • TABLE 61North America Human Diploid Cell Vaccine Market by Country, 2019 - 2022, USD Million
  • TABLE 62North America Human Diploid Cell Vaccine Market by Country, 2023 - 2030, USD Million
  • TABLE 63North America Vero Cell Rabies Vaccine Market by Country, 2019 - 2022, USD Million
  • TABLE 64North America Vero Cell Rabies Vaccine Market by Country, 2023 - 2030, USD Million
  • TABLE 65North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 66North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 67North America Rabies Vaccine Market by Country, 2019 - 2022, USD Million
  • TABLE 68North America Rabies Vaccine Market by Country, 2023 - 2030, USD Million
  • TABLE 69US Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 70US Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 71US Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 72US Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 73US Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 74US Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 75US Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 76US Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 77US Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 78US Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 79Canada Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 80Canada Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 81Canada Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 82Canada Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 83Canada Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 84Canada Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 85Canada Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 86Canada Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 87Canada Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 88Canada Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 89Mexico Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 90Mexico Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 91Mexico Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 92Mexico Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 93Mexico Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 94Mexico Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 95Mexico Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 96Mexico Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 97Mexico Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 98Mexico Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 99Rest of North America Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 100Rest of North America Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 101Rest of North America Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 102Rest of North America Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 103Rest of North America Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 104Rest of North America Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 105Rest of North America Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 106Rest of North America Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 107Rest of North America Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 108Rest of North America Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 109Europe Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 110Europe Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 111Europe Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 112Europe Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 113Europe Post-exposure Prophylaxis Market by Country, 2019 - 2022, USD Million
  • TABLE 114Europe Post-exposure Prophylaxis Market by Country, 2023 - 2030, USD Million
  • TABLE 115Europe Pre-exposure prophylaxis Market by Country, 2019 - 2022, USD Million
  • TABLE 116Europe Pre-exposure prophylaxis Market by Country, 2023 - 2030, USD Million
  • TABLE 117Europe Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 118Europe Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 119Europe Hospitals Market by Country, 2019 - 2022, USD Million
  • TABLE 120Europe Hospitals Market by Country, 2023 - 2030, USD Million
  • TABLE 121Europe Veterinary Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 122Europe Veterinary Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 123Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 124Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 125Europe Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 126Europe Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 127Europe Human Market by Country, 2019 - 2022, USD Million
  • TABLE 128Europe Human Market by Country, 2023 - 2030, USD Million
  • TABLE 129Europe Animal Market by Country, 2019 - 2022, USD Million
  • TABLE 130Europe Animal Market by Country, 2023 - 2030, USD Million
  • TABLE 131Europe Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 132Europe Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 133Europe Chick Embryo Cells Rabies Vaccine Market by Country, 2019 - 2022, USD Million
  • TABLE 134Europe Chick Embryo Cells Rabies Vaccine Market by Country, 2023 - 2030, USD Million
  • TABLE 135Europe Human Diploid Cell Vaccine Market by Country, 2019 - 2022, USD Million
  • TABLE 136Europe Human Diploid Cell Vaccine Market by Country, 2023 - 2030, USD Million
  • TABLE 137Europe Vero Cell Rabies Vaccine Market by Country, 2019 - 2022, USD Million
  • TABLE 138Europe Vero Cell Rabies Vaccine Market by Country, 2023 - 2030, USD Million
  • TABLE 139Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 140Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 141Europe Rabies Vaccine Market by Country, 2019 - 2022, USD Million
  • TABLE 142Europe Rabies Vaccine Market by Country, 2023 - 2030, USD Million
  • TABLE 143Germany Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 144Germany Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 145Germany Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 146Germany Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 147Germany Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 148Germany Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 149Germany Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 150Germany Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 151Germany Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 152Germany Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 153UK Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 154UK Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 155UK Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 156UK Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 157UK Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 158UK Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 159UK Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 160UK Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 161UK Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 162UK Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 163France Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 164France Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 165France Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 166France Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 167France Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 168France Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 169France Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 170France Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 171France Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 172France Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 173Russia Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 174Russia Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 175Russia Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 176Russia Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 177Russia Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 178Russia Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 179Russia Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 180Russia Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 181Russia Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 182Russia Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 183Spain Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 184Spain Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 185Spain Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 186Spain Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 187Spain Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 188Spain Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 189Spain Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 190Spain Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 191Spain Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 192Spain Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 193Italy Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 194Italy Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 195Italy Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 196Italy Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 197Italy Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 198Italy Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 199Italy Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 200Italy Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 201Italy Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 202Italy Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 203Rest of Europe Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 204Rest of Europe Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 205Rest of Europe Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 206Rest of Europe Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 207Rest of Europe Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 208Rest of Europe Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 209Rest of Europe Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 210Rest of Europe Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 211Rest of Europe Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 212Rest of Europe Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 213Asia Pacific Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 214Asia Pacific Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 215Asia Pacific Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 216Asia Pacific Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 217Asia Pacific Post-exposure Prophylaxis Market by Country, 2019 - 2022, USD Million
  • TABLE 218Asia Pacific Post-exposure Prophylaxis Market by Country, 2023 - 2030, USD Million
  • TABLE 219Asia Pacific Pre-exposure prophylaxis Market by Country, 2019 - 2022, USD Million
  • TABLE 220Asia Pacific Pre-exposure prophylaxis Market by Country, 2023 - 2030, USD Million
  • TABLE 221Asia Pacific Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 222Asia Pacific Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 223Asia Pacific Hospitals Market by Country, 2019 - 2022, USD Million
  • TABLE 224Asia Pacific Hospitals Market by Country, 2023 - 2030, USD Million
  • TABLE 225Asia Pacific Veterinary Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 226Asia Pacific Veterinary Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 227Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 228Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 229Asia Pacific Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 230Asia Pacific Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 231Asia Pacific Human Market by Country, 2019 - 2022, USD Million
  • TABLE 232Asia Pacific Human Market by Country, 2023 - 2030, USD Million
  • TABLE 233Asia Pacific Animal Market by Country, 2019 - 2022, USD Million
  • TABLE 234Asia Pacific Animal Market by Country, 2023 - 2030, USD Million
  • TABLE 235Asia Pacific Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 236Asia Pacific Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 237Asia Pacific Chick Embryo Cells Rabies Vaccine Market by Country, 2019 - 2022, USD Million
  • TABLE 238Asia Pacific Chick Embryo Cells Rabies Vaccine Market by Country, 2023 - 2030, USD Million
  • TABLE 239Asia Pacific Human Diploid Cell Vaccine Market by Country, 2019 - 2022, USD Million
  • TABLE 240Asia Pacific Human Diploid Cell Vaccine Market by Country, 2023 - 2030, USD Million
  • TABLE 241Asia Pacific Vero Cell Rabies Vaccine Market by Country, 2019 - 2022, USD Million
  • TABLE 242Asia Pacific Vero Cell Rabies Vaccine Market by Country, 2023 - 2030, USD Million
  • TABLE 243Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 244Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 245Asia Pacific Rabies Vaccine Market by Country, 2019 - 2022, USD Million
  • TABLE 246Asia Pacific Rabies Vaccine Market by Country, 2023 - 2030, USD Million
  • TABLE 247China Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 248China Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 249China Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 250China Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 251China Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 252China Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 253China Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 254China Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 255China Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 256China Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 257Japan Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 258Japan Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 259Japan Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 260Japan Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 261Japan Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 262Japan Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 263Japan Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 264Japan Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 265Japan Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 266Japan Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 267India Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 268India Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 269India Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 270India Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 271India Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 272India Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 273India Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 274India Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 275India Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 276India Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 277South Korea Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 278South Korea Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 279South Korea Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 280South Korea Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 281South Korea Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 282South Korea Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 283South Korea Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 284South Korea Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 285South Korea Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 286South Korea Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 287Singapore Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 288Singapore Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 289Singapore Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 290Singapore Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 291Singapore Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 292Singapore Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 293Singapore Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 294Singapore Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 295Singapore Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 296Singapore Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 297Malaysia Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 298Malaysia Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 299Malaysia Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 300Malaysia Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 301Malaysia Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 302Malaysia Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 303Malaysia Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 304Malaysia Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 305Malaysia Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 306Malaysia Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 307Rest of Asia Pacific Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 308Rest of Asia Pacific Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 309Rest of Asia Pacific Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 310Rest of Asia Pacific Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 311Rest of Asia Pacific Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 312Rest of Asia Pacific Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 313Rest of Asia Pacific Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 314Rest of Asia Pacific Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 315Rest of Asia Pacific Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 316Rest of Asia Pacific Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 317LAMEA Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 318LAMEA Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 319LAMEA Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 320LAMEA Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 321LAMEA Post-exposure Prophylaxis Market by Country, 2019 - 2022, USD Million
  • TABLE 322LAMEA Post-exposure Prophylaxis Market by Country, 2023 - 2030, USD Million
  • TABLE 323LAMEA Pre-exposure prophylaxis Market by Country, 2019 - 2022, USD Million
  • TABLE 324LAMEA Pre-exposure prophylaxis Market by Country, 2023 - 2030, USD Million
  • TABLE 325LAMEA Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 326LAMEA Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 327LAMEA Hospitals Market by Country, 2019 - 2022, USD Million
  • TABLE 328LAMEA Hospitals Market by Country, 2023 - 2030, USD Million
  • TABLE 329LAMEA Veterinary Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 330LAMEA Veterinary Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 331LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 332LAMEA Others Market by Country, 2023 - 2030, USD Million
  • TABLE 333LAMEA Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 334LAMEA Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 335LAMEA Human Market by Country, 2019 - 2022, USD Million
  • TABLE 336LAMEA Human Market by Country, 2023 - 2030, USD Million
  • TABLE 337LAMEA Animal Market by Country, 2019 - 2022, USD Million
  • TABLE 338LAMEA Animal Market by Country, 2023 - 2030, USD Million
  • TABLE 339LAMEA Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 340LAMEA Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 341LAMEA Chick Embryo Cells Rabies Vaccine Market by Country, 2019 - 2022, USD Million
  • TABLE 342LAMEA Chick Embryo Cells Rabies Vaccine Market by Country, 2023 - 2030, USD Million
  • TABLE 343LAMEA Human Diploid Cell Vaccine Market by Country, 2019 - 2022, USD Million
  • TABLE 344LAMEA Human Diploid Cell Vaccine Market by Country, 2023 - 2030, USD Million
  • TABLE 345LAMEA Vero Cell Rabies Vaccine Market by Country, 2019 - 2022, USD Million
  • TABLE 346LAMEA Vero Cell Rabies Vaccine Market by Country, 2023 - 2030, USD Million
  • TABLE 347LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 348LAMEA Others Market by Country, 2023 - 2030, USD Million
  • TABLE 349LAMEA Rabies Vaccine Market by Country, 2019 - 2022, USD Million
  • TABLE 350LAMEA Rabies Vaccine Market by Country, 2023 - 2030, USD Million
  • TABLE 351Brazil Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 352Brazil Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 353Brazil Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 354Brazil Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 355Brazil Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 356Brazil Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 357Brazil Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 358Brazil Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 359Brazil Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 360Brazil Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 361Argentina Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 362Argentina Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 363Argentina Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 364Argentina Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 365Argentina Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 366Argentina Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 367Argentina Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 368Argentina Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 369Argentina Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 370Argentina Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 371UAE Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 372UAE Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 373UAE Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 374UAE Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 375UAE Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 376UAE Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 377UAE Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 378UAE Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 379UAE Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 380UAE Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 381Saudi Arabia Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 382Saudi Arabia Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 383Saudi Arabia Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 384Saudi Arabia Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 385Saudi Arabia Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 386Saudi Arabia Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 387Saudi Arabia Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 388Saudi Arabia Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 389Saudi Arabia Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 390Saudi Arabia Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 391South Africa Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 392South Africa Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 393South Africa Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 394South Africa Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 395South Africa Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 396South Africa Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 397South Africa Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 398South Africa Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 399South Africa Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 400South Africa Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 401Nigeria Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 402Nigeria Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 403Nigeria Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 404Nigeria Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 405Nigeria Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 406Nigeria Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 407Nigeria Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 408Nigeria Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 409Nigeria Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 410Nigeria Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 411Rest of LAMEA Rabies Vaccine Market, 2019 - 2022, USD Million
  • TABLE 412Rest of LAMEA Rabies Vaccine Market, 2023 - 2030, USD Million
  • TABLE 413Rest of LAMEA Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
  • TABLE 414Rest of LAMEA Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
  • TABLE 415Rest of LAMEA Rabies Vaccine Market by End User, 2019 - 2022, USD Million
  • TABLE 416Rest of LAMEA Rabies Vaccine Market by End User, 2023 - 2030, USD Million
  • TABLE 417Rest of LAMEA Rabies Vaccine Market by Application, 2019 - 2022, USD Million
  • TABLE 418Rest of LAMEA Rabies Vaccine Market by Application, 2023 - 2030, USD Million
  • TABLE 419Rest of LAMEA Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
  • TABLE 420Rest of LAMEA Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
  • TABLE 421Key Information - Cadila Pharmaceuticals Limited
  • TABLE 422Key Information - Bharat Biotech Ltd.
  • TABLE 423Key Information - Serum Institute of India Pvt. Ltd.
  • TABLE 424Key Information - Boehringer Ingelheim International GmbH
  • TABLE 425Key information - Elanco Animal Health, Inc.
  • TABLE 426Key Information - Zoetis, Inc.
  • TABLE 427Key Information - Merck & Co., Inc.
  • TABLE 428Key Information - Novartis AG
  • TABLE 429Key Information - Sanofi S.A.
  • TABLE 430Key Information - Virbac
目次

The Global Rabies Vaccine Market size is expected to reach $1.6 billion by 2030, rising at a market growth of 4.5% CAGR during the forecast period.

Pet owners increasingly adopt preventive healthcare practices for their animals, mirroring trends in human healthcare. Regular veterinary visits, including vaccinations, are proactive measures to protect pets from diseases such as rabies, fostering a continuous demand for vaccines. Consequently, the Veterinary clinics segment would acquire nearly, 20% market share by 2030. Advancements in veterinary medicine, including the availability of improved and safer vaccines, contribute to a positive perception of vaccinations among pet owners.

Ongoing R&D activities focus on improving the formulation of these vaccines. Researchers work to enhance vaccine stability, reduce adverse reactions, and optimize the immune response. R&D efforts aim to develop next-generation vaccines with enhanced characteristics. This may include vaccines with longer-lasting immunity, novel delivery methods, and the ability to protect against a broader spectrum of rabies virus variants. Therefore, the market is expanding significantly due to the rising research and development (R&D) initiatives. Additionally, Rabies poses a severe threat to human health as it can be transmitted through the saliva of infected animals, primarily through bites or scratches. Zoonotic diseases often transcend national borders, necessitating global collaboration. Collaborative efforts and funding support facilitate the implementation of vaccination programs to control and eliminate rabies, particularly in regions where the disease poses a significant zoonotic threat. Hence, increasing awareness of zoonotic diseases like rabies has been a pivotal factor in driving the growth of the market.

Moreover, The COVID-19 pandemic disrupted routine healthcare services, including vaccination programs. Lockdowns, restrictions on movement, and healthcare system strain may affect the implementation of rabies vaccination campaigns, particularly in regions with limited resources. Travel restrictions and disruptions in global transportation may affected the movement of professionals involved in global health initiatives and collaborations. This impact global efforts to control and eliminate rabies. Thus, the COVID-19 pandemic had a moderate effect on the market.

However, High vaccination program costs can restrict access to these vaccines, particularly in resource-constrained areas. Governments responsible for public health initiatives may experience financial strain when implementing rabies vaccination programs. The allocation of resources to these programs may compete with other essential healthcare needs, potentially leading to budget constraints. Thus, high cost can slow down the growth of the market.

By Prophylaxis Type Analysis

Based on prophylaxis type, the market is classified into pre-exposure prophylaxis and post-exposure prophylaxis. The pre-exposure prophylaxis segment acquired a 40% revenue share in the market in 2022. Pre-exposure prophylaxis offers long-term protection, reducing the need for immediate post-exposure treatment for potential rabies exposure. This long-term protection can be cost-effective in the long run, considering the expenses associated with post-exposure prophylaxis.

By End User Analysis

Based on end user, the market is segmented into hospitals, veterinary clinics, and others. The veterinary clinics segment recorded a 20% revenue share in the market in 2022. A greater demand for veterinary services, such as rabies vaccination, has resulted from the global rise in the prevalence of pet ownership. Routine vaccination programs are integral to the preventive healthcare veterinary clinics provide to pets, including dogs and cats.

By Application Analysis

On the basis of application, the market is bifurcated into human and animal. The animal segment garnered a 30% revenue share in the market in 2022. Animals, particularly mammals, serve as the primary reservoirs of the rabies virus. Controlling rabies in animal populations is essential to reduce the risk of transmission to humans through bites or scratches.

By Product Type Analysis

By product type, the market is categorized into chick embryo cells rabies vaccine, Vero cell rabies vaccine, human diploid cell vaccine, and others. The Vero cell rabies vaccine segment covered a 20% revenue share in the market in 2022. The Vero cell vaccine eliminates the use of nervous tissue in its production, addressing safety concerns associated with traditional nerve tissue-derived vaccines. Removing nervous tissue reduces the risk of adverse reactions, making the Vero cell vaccine a safer option for rabies prevention.

By Regional Analysis

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating 40% revenue share. North America's health authorities and veterinary services implement strategic vaccination programs targeting domestic and wildlife populations. Veterinary clinics and practices across North America actively participate in rabies prevention by providing pet vaccination services.

List of Key Companies Profiled

  • Boehringer Ingelheim International GmbH
  • Cadila Pharmaceuticals Limited
  • Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group)
  • Elanco Animal Health, Inc.
  • Zoetis, Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Bharat Biotech Ltd.
  • Sanofi S.A.
  • Virbac

Global Rabies Vaccine Market Report Segmentation

By Prophylaxis Type

  • Post-exposure Prophylaxis
  • Pre-exposure prophylaxis

By End User

  • Hospitals
  • Veterinary Clinics
  • Others

By Application

  • Human
  • Animal

By Product Type

  • Chick Embryo Cells Rabies Vaccine
  • Human Diploid Cell Vaccine
  • Vero cell rabies vaccine
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Table of Contents

Chapter 1.Market Scope & Methodology

  • 1.1Market Definition
  • 1.2Objectives
  • 1.3Market Scope
  • 1.4Segmentation
    • 1.4.1Global Rabies Vaccine Market, by Prophylaxis Type
    • 1.4.2Global Rabies Vaccine Market, by End User
    • 1.4.3Global Rabies Vaccine Market, by Application
    • 1.4.4Global Rabies Vaccine Market, by Product Type
    • 1.4.5Global Rabies Vaccine Market, by Geography
  • 1.5Methodology for the research

Chapter 2.Market at a Glance

  • 2.1Key Highlights

Chapter 3.Market Overview

  • 3.1Introduction
    • 3.1.1Overview
      • 3.1.1.1Market Composition and Scenario
  • 3.2Key Factors Impacting the Market
    • 3.2.1Market Drivers
    • 3.2.2Market Opportunities
    • 3.2.3Market Restraints
    • 3.2.4Market Challenges
  • 3.3Porter Five Forces Analysis

Chapter 4.Global Rabies Vaccine Market by Prophylaxis Type

  • 4.1Global Post-exposure Prophylaxis Market by Region
  • 4.2Global Pre-exposure prophylaxis Market by Region

Chapter 5.Global Rabies Vaccine Market by End User

  • 5.1Global Hospitals Market by Region
  • 5.2Global Veterinary Clinics Market by Region
  • 5.3Global Others Market by Region

Chapter 6.Global Rabies Vaccine Market by Application

  • 6.1Global Human Market by Region
  • 6.2Global Animal Market by Region

Chapter 7.Global Rabies Vaccine Market by Product Type

  • 7.1Global Chick Embryo Cells Rabies Vaccine Market by Region
  • 7.2Global Human Diploid Cell Vaccine Market by Region
  • 7.3Global Vero Cell Rabies Vaccine Market by Region
  • 7.4Global Others Market by Region

Chapter 8.Global Rabies Vaccine Market by Region

  • 8.1North America Rabies Vaccine Market
    • 8.1.1North America Rabies Vaccine Market by Prophylaxis Type
      • 8.1.1.1North America Post-exposure Prophylaxis Market by Region
      • 8.1.1.2North America Pre-exposure prophylaxis Market by Region
    • 8.1.2North America Rabies Vaccine Market by End User
      • 8.1.2.1North America Hospitals Market by Country
      • 8.1.2.2North America Veterinary Clinics Market by Country
      • 8.1.2.3North America Others Market by Country
    • 8.1.3North America Rabies Vaccine Market by Application
      • 8.1.3.1North America Human Market by Country
      • 8.1.3.2North America Animal Market by Country
    • 8.1.4North America Rabies Vaccine Market by Product Type
      • 8.1.4.1North America Chick Embryo Cells Rabies Vaccine Market by Country
      • 8.1.4.2North America Human Diploid Cell Vaccine Market by Country
      • 8.1.4.3North America Vero Cell Rabies Vaccine Market by Country
      • 8.1.4.4North America Others Market by Country
    • 8.1.5North America Rabies Vaccine Market by Country
      • 8.1.5.1US Rabies Vaccine Market
        • 8.1.5.1.1US Rabies Vaccine Market by Prophylaxis Type
        • 8.1.5.1.2US Rabies Vaccine Market by End User
        • 8.1.5.1.3US Rabies Vaccine Market by Application
        • 8.1.5.1.4US Rabies Vaccine Market by Product Type
      • 8.1.5.2Canada Rabies Vaccine Market
        • 8.1.5.2.1Canada Rabies Vaccine Market by Prophylaxis Type
        • 8.1.5.2.2Canada Rabies Vaccine Market by End User
        • 8.1.5.2.3Canada Rabies Vaccine Market by Application
        • 8.1.5.2.4Canada Rabies Vaccine Market by Product Type
      • 8.1.5.3Mexico Rabies Vaccine Market
        • 8.1.5.3.1Mexico Rabies Vaccine Market by Prophylaxis Type
        • 8.1.5.3.2Mexico Rabies Vaccine Market by End User
        • 8.1.5.3.3Mexico Rabies Vaccine Market by Application
        • 8.1.5.3.4Mexico Rabies Vaccine Market by Product Type
      • 8.1.5.4Rest of North America Rabies Vaccine Market
        • 8.1.5.4.1Rest of North America Rabies Vaccine Market by Prophylaxis Type
        • 8.1.5.4.2Rest of North America Rabies Vaccine Market by End User
        • 8.1.5.4.3Rest of North America Rabies Vaccine Market by Application
        • 8.1.5.4.4Rest of North America Rabies Vaccine Market by Product Type
  • 8.2Europe Rabies Vaccine Market
    • 8.2.1Europe Rabies Vaccine Market by Prophylaxis Type
      • 8.2.1.1Europe Post-exposure Prophylaxis Market by Country
      • 8.2.1.2Europe Pre-exposure prophylaxis Market by Country
    • 8.2.2Europe Rabies Vaccine Market by End User
      • 8.2.2.1Europe Hospitals Market by Country
      • 8.2.2.2Europe Veterinary Clinics Market by Country
      • 8.2.2.3Europe Others Market by Country
    • 8.2.3Europe Rabies Vaccine Market by Application
      • 8.2.3.1Europe Human Market by Country
      • 8.2.3.2Europe Animal Market by Country
    • 8.2.4Europe Rabies Vaccine Market by Product Type
      • 8.2.4.1Europe Chick Embryo Cells Rabies Vaccine Market by Country
      • 8.2.4.2Europe Human Diploid Cell Vaccine Market by Country
      • 8.2.4.3Europe Vero Cell Rabies Vaccine Market by Country
      • 8.2.4.4Europe Others Market by Country
    • 8.2.5Europe Rabies Vaccine Market by Country
      • 8.2.5.1Germany Rabies Vaccine Market
        • 8.2.5.1.1Germany Rabies Vaccine Market by Prophylaxis Type
        • 8.2.5.1.2Germany Rabies Vaccine Market by End User
        • 8.2.5.1.3Germany Rabies Vaccine Market by Application
        • 8.2.5.1.4Germany Rabies Vaccine Market by Product Type
      • 8.2.5.2UK Rabies Vaccine Market
        • 8.2.5.2.1UK Rabies Vaccine Market by Prophylaxis Type
        • 8.2.5.2.2UK Rabies Vaccine Market by End User
        • 8.2.5.2.3UK Rabies Vaccine Market by Application
        • 8.2.5.2.4UK Rabies Vaccine Market by Product Type
      • 8.2.5.3France Rabies Vaccine Market
        • 8.2.5.3.1France Rabies Vaccine Market by Prophylaxis Type
        • 8.2.5.3.2France Rabies Vaccine Market by End User
        • 8.2.5.3.3France Rabies Vaccine Market by Application
        • 8.2.5.3.4France Rabies Vaccine Market by Product Type
      • 8.2.5.4Russia Rabies Vaccine Market
        • 8.2.5.4.1Russia Rabies Vaccine Market by Prophylaxis Type
        • 8.2.5.4.2Russia Rabies Vaccine Market by End User
        • 8.2.5.4.3Russia Rabies Vaccine Market by Application
        • 8.2.5.4.4Russia Rabies Vaccine Market by Product Type
      • 8.2.5.5Spain Rabies Vaccine Market
        • 8.2.5.5.1Spain Rabies Vaccine Market by Prophylaxis Type
        • 8.2.5.5.2Spain Rabies Vaccine Market by End User
        • 8.2.5.5.3Spain Rabies Vaccine Market by Application
        • 8.2.5.5.4Spain Rabies Vaccine Market by Product Type
      • 8.2.5.6Italy Rabies Vaccine Market
        • 8.2.5.6.1Italy Rabies Vaccine Market by Prophylaxis Type
        • 8.2.5.6.2Italy Rabies Vaccine Market by End User
        • 8.2.5.6.3Italy Rabies Vaccine Market by Application
        • 8.2.5.6.4Italy Rabies Vaccine Market by Product Type
      • 8.2.5.7Rest of Europe Rabies Vaccine Market
        • 8.2.5.7.1Rest of Europe Rabies Vaccine Market by Prophylaxis Type
        • 8.2.5.7.2Rest of Europe Rabies Vaccine Market by End User
        • 8.2.5.7.3Rest of Europe Rabies Vaccine Market by Application
        • 8.2.5.7.4Rest of Europe Rabies Vaccine Market by Product Type
  • 8.3Asia Pacific Rabies Vaccine Market
    • 8.3.1Asia Pacific Rabies Vaccine Market by Prophylaxis Type
      • 8.3.1.1Asia Pacific Post-exposure Prophylaxis Market by Country
      • 8.3.1.2Asia Pacific Pre-exposure prophylaxis Market by Country
    • 8.3.2Asia Pacific Rabies Vaccine Market by End User
      • 8.3.2.1Asia Pacific Hospitals Market by Country
      • 8.3.2.2Asia Pacific Veterinary Clinics Market by Country
      • 8.3.2.3Asia Pacific Others Market by Country
    • 8.3.3Asia Pacific Rabies Vaccine Market by Application
      • 8.3.3.1Asia Pacific Human Market by Country
      • 8.3.3.2Asia Pacific Animal Market by Country
    • 8.3.4Asia Pacific Rabies Vaccine Market by Product Type
      • 8.3.4.1Asia Pacific Chick Embryo Cells Rabies Vaccine Market by Country
      • 8.3.4.2Asia Pacific Human Diploid Cell Vaccine Market by Country
      • 8.3.4.3Asia Pacific Vero Cell Rabies Vaccine Market by Country
      • 8.3.4.4Asia Pacific Others Market by Country
    • 8.3.5Asia Pacific Rabies Vaccine Market by Country
      • 8.3.5.1China Rabies Vaccine Market
        • 8.3.5.1.1China Rabies Vaccine Market by Prophylaxis Type
        • 8.3.5.1.2China Rabies Vaccine Market by End User
        • 8.3.5.1.3China Rabies Vaccine Market by Application
        • 8.3.5.1.4China Rabies Vaccine Market by Product Type
      • 8.3.5.2Japan Rabies Vaccine Market
        • 8.3.5.2.1Japan Rabies Vaccine Market by Prophylaxis Type
        • 8.3.5.2.2Japan Rabies Vaccine Market by End User
        • 8.3.5.2.3Japan Rabies Vaccine Market by Application
        • 8.3.5.2.4Japan Rabies Vaccine Market by Product Type
      • 8.3.5.3India Rabies Vaccine Market
        • 8.3.5.3.1India Rabies Vaccine Market by Prophylaxis Type
        • 8.3.5.3.2India Rabies Vaccine Market by End User
        • 8.3.5.3.3India Rabies Vaccine Market by Application
        • 8.3.5.3.4India Rabies Vaccine Market by Product Type
      • 8.3.5.4South Korea Rabies Vaccine Market
        • 8.3.5.4.1South Korea Rabies Vaccine Market by Prophylaxis Type
        • 8.3.5.4.2South Korea Rabies Vaccine Market by End User
        • 8.3.5.4.3South Korea Rabies Vaccine Market by Application
        • 8.3.5.4.4South Korea Rabies Vaccine Market by Product Type
      • 8.3.5.5Singapore Rabies Vaccine Market
        • 8.3.5.5.1Singapore Rabies Vaccine Market by Prophylaxis Type
        • 8.3.5.5.2Singapore Rabies Vaccine Market by End User
        • 8.3.5.5.3Singapore Rabies Vaccine Market by Application
        • 8.3.5.5.4Singapore Rabies Vaccine Market by Product Type
      • 8.3.5.6Malaysia Rabies Vaccine Market
        • 8.3.5.6.1Malaysia Rabies Vaccine Market by Prophylaxis Type
        • 8.3.5.6.2Malaysia Rabies Vaccine Market by End User
        • 8.3.5.6.3Malaysia Rabies Vaccine Market by Application
        • 8.3.5.6.4Malaysia Rabies Vaccine Market by Product Type
      • 8.3.5.7Rest of Asia Pacific Rabies Vaccine Market
        • 8.3.5.7.1Rest of Asia Pacific Rabies Vaccine Market by Prophylaxis Type
        • 8.3.5.7.2Rest of Asia Pacific Rabies Vaccine Market by End User
        • 8.3.5.7.3Rest of Asia Pacific Rabies Vaccine Market by Application
        • 8.3.5.7.4Rest of Asia Pacific Rabies Vaccine Market by Product Type
  • 8.4LAMEA Rabies Vaccine Market
    • 8.4.1LAMEA Rabies Vaccine Market by Prophylaxis Type
      • 8.4.1.1LAMEA Post-exposure Prophylaxis Market by Country
      • 8.4.1.2LAMEA Pre-exposure prophylaxis Market by Country
    • 8.4.2LAMEA Rabies Vaccine Market by End User
      • 8.4.2.1LAMEA Hospitals Market by Country
      • 8.4.2.2LAMEA Veterinary Clinics Market by Country
      • 8.4.2.3LAMEA Others Market by Country
    • 8.4.3LAMEA Rabies Vaccine Market by Application
      • 8.4.3.1LAMEA Human Market by Country
      • 8.4.3.2LAMEA Animal Market by Country
    • 8.4.4LAMEA Rabies Vaccine Market by Product Type
      • 8.4.4.1LAMEA Chick Embryo Cells Rabies Vaccine Market by Country
      • 8.4.4.2LAMEA Human Diploid Cell Vaccine Market by Country
      • 8.4.4.3LAMEA Vero Cell Rabies Vaccine Market by Country
      • 8.4.4.4LAMEA Others Market by Country
    • 8.4.5LAMEA Rabies Vaccine Market by Country
      • 8.4.5.1Brazil Rabies Vaccine Market
        • 8.4.5.1.1Brazil Rabies Vaccine Market by Prophylaxis Type
        • 8.4.5.1.2Brazil Rabies Vaccine Market by End User
        • 8.4.5.1.3Brazil Rabies Vaccine Market by Application
        • 8.4.5.1.4Brazil Rabies Vaccine Market by Product Type
      • 8.4.5.2Argentina Rabies Vaccine Market
        • 8.4.5.2.1Argentina Rabies Vaccine Market by Prophylaxis Type
        • 8.4.5.2.2Argentina Rabies Vaccine Market by End User
        • 8.4.5.2.3Argentina Rabies Vaccine Market by Application
        • 8.4.5.2.4Argentina Rabies Vaccine Market by Product Type
      • 8.4.5.3UAE Rabies Vaccine Market
        • 8.4.5.3.1UAE Rabies Vaccine Market by Prophylaxis Type
        • 8.4.5.3.2UAE Rabies Vaccine Market by End User
        • 8.4.5.3.3UAE Rabies Vaccine Market by Application
        • 8.4.5.3.4UAE Rabies Vaccine Market by Product Type
      • 8.4.5.4Saudi Arabia Rabies Vaccine Market
        • 8.4.5.4.1Saudi Arabia Rabies Vaccine Market by Prophylaxis Type
        • 8.4.5.4.2Saudi Arabia Rabies Vaccine Market by End User
        • 8.4.5.4.3Saudi Arabia Rabies Vaccine Market by Application
        • 8.4.5.4.4Saudi Arabia Rabies Vaccine Market by Product Type
      • 8.4.5.5South Africa Rabies Vaccine Market
        • 8.4.5.5.1South Africa Rabies Vaccine Market by Prophylaxis Type
        • 8.4.5.5.2South Africa Rabies Vaccine Market by End User
        • 8.4.5.5.3South Africa Rabies Vaccine Market by Application
        • 8.4.5.5.4South Africa Rabies Vaccine Market by Product Type
      • 8.4.5.6Nigeria Rabies Vaccine Market
        • 8.4.5.6.1Nigeria Rabies Vaccine Market by Prophylaxis Type
        • 8.4.5.6.2Nigeria Rabies Vaccine Market by End User
        • 8.4.5.6.3Nigeria Rabies Vaccine Market by Application
        • 8.4.5.6.4Nigeria Rabies Vaccine Market by Product Type
      • 8.4.5.7Rest of LAMEA Rabies Vaccine Market
        • 8.4.5.7.1Rest of LAMEA Rabies Vaccine Market by Prophylaxis Type
        • 8.4.5.7.2Rest of LAMEA Rabies Vaccine Market by End User
        • 8.4.5.7.3Rest of LAMEA Rabies Vaccine Market by Application
        • 8.4.5.7.4Rest of LAMEA Rabies Vaccine Market by Product Type

Chapter 9.Company Profiles

  • 9.1Cadila Pharmaceuticals Limited
    • 9.1.1Company Overview
    • 9.1.2Recent strategies and developments:
      • 9.1.2.1Product Launches and Product Expansions:
  • 9.2Bharat Biotech Ltd.
    • 9.2.1Company Overview
  • 9.3Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group)
    • 9.3.1Company Overview
  • 9.4Boehringer Ingelheim International GmbH
    • 9.4.1Company Overview
    • 9.4.2Financial Analysis
    • 9.4.3Regional & Segmental Analysis
    • 9.4.4Research & Development Expenses
    • 9.4.5SWOT Analysis
  • 9.5Elanco Animal Health, Inc.
    • 9.5.1Company Overview
    • 9.5.2Financial Analysis
    • 9.5.3Regional Analysis
    • 9.5.4Research & Development Expense
    • 9.5.5SWOT Analysis
  • 9.6Zoetis, Inc.
    • 9.6.1Company Overview
    • 9.6.2Financial Analysis
    • 9.6.3Regional Analysis
    • 9.6.4Research & Development Expense
    • 9.6.5SWOT Analysis
  • 9.7Merck & Co., Inc.
    • 9.7.1Company Overview
    • 9.7.2Financial Analysis
    • 9.7.3Segmental and Regional Analysis
    • 9.7.4Research & Development Expenses
    • 9.7.5SWOT Analysis
  • 9.8Novartis AG
    • 9.8.1Company Overview
    • 9.8.2Financial Analysis
    • 9.8.3Segmental and Regional Analysis
    • 9.8.4Research & Development Expense
    • 9.8.5SWOT Analysis
  • 9.9Sanofi S.A.
    • 9.9.1Company Overview
    • 9.9.2Financial Analysis
    • 9.9.3Segmental and Regional Analysis
    • 9.9.4Research & Development Expense
    • 9.9.5SWOT Analysis
  • 9.10.Virbac
    • 9.10.1Company Overview
    • 9.10.2Financial Analysis
    • 9.10.3Regional Analysis
    • 9.10.4SWOT Analysis

Chapter 10.Winning imperative of Rabies Vaccine Market